ProQR Therapeutics (PRQR) Prepaid Assets (2013 - 2025)
ProQR Therapeutics recorded quarterly Prepaid Assets of $3.1 million in Q4 2025, up 18.74% quarter-over-quarter from $2.6 million in Q4 2024, and up 18.74% year-over-year from $2.6 million in Q4 2024.
ProQR Therapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $3.1 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 18.74% year-over-year to $3.1 million; the TTM figure through Dec 2025 stood at $3.1 million (up 18.74% YoY), while the FY2025 annual figure was $3.1 million, up 18.74% from the prior year.
- Prepaid Assets came in at $3.1 million for Q4 2025 at ProQR Therapeutics, up from $2.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $60.3 million in Q4 2022 to a low of $5469.1 in Q1 2021.
- A 5-year average of $9.2 million and a median of $3.9 million in 2021 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets sank 99.75% in 2021 and jumped 82950.63% in 2022, its largest moves.
- ProQR Therapeutics' Prepaid Assets stood at $3.9 million in 2021, then soared by 1447.84% to $60.3 million in 2022, then sank by 93.49% to $3.9 million in 2023, then slumped by 34.38% to $2.6 million in 2024, then rose by 18.74% to $3.1 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $3.1 million, $2.6 million, and $3.9 million for Q4 2025, Q4 2024, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.06 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 2.38 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 60.27 Mn |
| Sep 30, 2022 | 3.13 Mn |
| Jun 30, 2022 | 4.44 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 24.07 Mn |
| Jun 30, 2021 | 4.53 Mn |
| Mar 31, 2021 | 5,469.07 |
| Dec 31, 2020 | 4.49 Mn |
| Sep 30, 2020 | 3.22 Mn |
| Jun 30, 2020 | 3.92 Mn |
| Mar 31, 2020 | 2.19 Mn |
| Dec 31, 2019 | 2.07 Mn |
| Sep 30, 2019 | 2.73 Mn |
| Jun 30, 2019 | 2.43 Mn |
| Mar 31, 2019 | 2.37 |
| Dec 31, 2018 | 1,762.32 |
| Sep 30, 2018 | 2.30 |
| Jun 30, 2018 | 1.57 Mn |
| Mar 31, 2018 | 1,185.53 |
| Dec 31, 2017 | 2,430.22 |
| Sep 30, 2016 | 4,087.47 |
| Dec 31, 2015 | 2,135.24 |
| Mar 31, 2015 | 1.75 Mn |
| Dec 31, 2014 | 918,627.61 |
| Dec 31, 2013 | 80,304.28 |